tiprankstipranks
Elanco Animal Health (ELAN)
NYSE:ELAN
US Market
ELAN
Elanco Animal Health
RESEARCH TOOLSreports
Want to see ELAN full AI Analyst Report?

Elanco Animal Health (ELAN) Stock Forecast & Price Target

485 Followers
See the Price Targets and Ratings of:

ELAN Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Elanco
Animal Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ELAN Stock 12 Month Forecast

Average Price Target

$31.33
▲(23.31% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Elanco Animal Health in the last 3 months. The average price target is $31.33 with a high forecast of $34.00 and a low forecast of $26.00. The average price target represents a 23.31% change from the last price of $25.41.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","35":"$35","17.75":"$17.75","23.5":"$23.5","29.25":"$29.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$34.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.333333333333332,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$26.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,17.75,23.5,29.25,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.95692307692308,27.543846153846154,28.130769230769232,28.71769230769231,29.304615384615385,29.891538461538463,30.478461538461538,31.065384615384616,31.652307692307694,32.23923076923077,32.826153846153844,33.41307692307692,{"y":34,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.75179487179487,27.133589743589745,27.515384615384615,27.89717948717949,28.27897435897436,28.66076923076923,29.042564102564103,29.424358974358974,29.806153846153848,30.187948717948718,30.569743589743588,30.951538461538462,{"y":31.333333333333332,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.341538461538462,26.313076923076924,26.284615384615385,26.256153846153847,26.22769230769231,26.19923076923077,26.17076923076923,26.142307692307693,26.113846153846154,26.085384615384616,26.056923076923077,26.02846153846154,{"y":26,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.15,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.62,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.63,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.75,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.09,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.12,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.51,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.67,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.09,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.37,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$34.00Average Price Target$31.33Lowest Price Target$26.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on ELAN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$32→$34
Buy
33.81%
Upside
Reiterated
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
William Blair Analyst forecast on ELAN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
08/12/26
Analysts Are Bullish on These Healthcare Stocks: Spectral AI (MDAI), Elanco Animal Health (ELAN)
J.P. Morgan Analyst forecast on ELAN
Chris Schott
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and ACADIA Pharmaceuticals (NASDAQ: ACAD)
Morgan Stanley Analyst forecast on ELAN
Erin Wright
Morgan Stanley
Morgan Stanley
$26
Hold
2.32%
Upside
Assigned
08/10/26
Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)
Piper Sandler Analyst forecast on ELAN
David Westenberg
Piper Sandler
Piper Sandler
$30
Buy
18.06%
Upside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stifel Nicolaus Analyst forecast on ELAN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$32→$33
Buy
29.87%
Upside
Reiterated
08/06/26
Analysts' Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)
UBS Analyst forecast on ELAN
Andrea Alfonso
UBS
UBS
$31→$33
Buy
29.87%
Upside
Reiterated
08/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NYSE: NVST) and Elanco Animal Health (NYSE: ELAN)
Citi Analyst forecast on ELAN
Daniel Grosslight
Citi
Citi
$31→$34
Buy
33.81%
Upside
Reiterated
08/06/26
Elanco price target raised to $34 from $31 at CitiElanco price target raised to $34 from $31 at Citi
KeyBanc Analyst forecast on ELAN
Scott Schoenhaus
KeyBanc
KeyBanc
$30
Buy
18.06%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (NASDAQ: LFCR), Elanco Animal Health (NYSE: ELAN) and Alpha Teknova (NASDAQ: TKNO)
Argus Research Analyst forecast on ELAN
Jasper Hellweg
Argus Research
Argus Research
―
Buy
―
Reiterated
06/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on ELAN
Steve Scala
TD Cowen
TD Cowen
$31→$32
Buy
25.93%
Upside
Assigned
06/18/26
Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook
Barclays Analyst forecast on ELAN
Glen Santangelo
Barclays
Barclays
$30
Buy
18.06%
Upside
Reiterated
06/11/26
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Evercore ISI Analyst forecast on ELAN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
Jefferies Analyst forecast on ELAN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$30
Buy
18.06%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Daniel Clark
Leerink Partners
Leerink Partners
$30
Buy
18.06%
Upside
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on ELAN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$32→$34
Buy
33.81%
Upside
Reiterated
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
William Blair Analyst forecast on ELAN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
08/12/26
Analysts Are Bullish on These Healthcare Stocks: Spectral AI (MDAI), Elanco Animal Health (ELAN)
J.P. Morgan Analyst forecast on ELAN
Chris Schott
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and ACADIA Pharmaceuticals (NASDAQ: ACAD)
Morgan Stanley Analyst forecast on ELAN
Erin Wright
Morgan Stanley
Morgan Stanley
$26
Hold
2.32%
Upside
Assigned
08/10/26
Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)
Piper Sandler Analyst forecast on ELAN
David Westenberg
Piper Sandler
Piper Sandler
$30
Buy
18.06%
Upside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stifel Nicolaus Analyst forecast on ELAN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$32→$33
Buy
29.87%
Upside
Reiterated
08/06/26
Analysts' Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)
UBS Analyst forecast on ELAN
Andrea Alfonso
UBS
UBS
$31→$33
Buy
29.87%
Upside
Reiterated
08/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NYSE: NVST) and Elanco Animal Health (NYSE: ELAN)
Citi Analyst forecast on ELAN
Daniel Grosslight
Citi
Citi
$31→$34
Buy
33.81%
Upside
Reiterated
08/06/26
Elanco price target raised to $34 from $31 at CitiElanco price target raised to $34 from $31 at Citi
KeyBanc Analyst forecast on ELAN
Scott Schoenhaus
KeyBanc
KeyBanc
$30
Buy
18.06%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (NASDAQ: LFCR), Elanco Animal Health (NYSE: ELAN) and Alpha Teknova (NASDAQ: TKNO)
Argus Research Analyst forecast on ELAN
Jasper Hellweg
Argus Research
Argus Research
―
Buy
―
Reiterated
06/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on ELAN
Steve Scala
TD Cowen
TD Cowen
$31→$32
Buy
25.93%
Upside
Assigned
06/18/26
Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook
Barclays Analyst forecast on ELAN
Glen Santangelo
Barclays
Barclays
$30
Buy
18.06%
Upside
Reiterated
06/11/26
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Evercore ISI Analyst forecast on ELAN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
Jefferies Analyst forecast on ELAN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$30
Buy
18.06%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Daniel Clark
Leerink Partners
Leerink Partners
$30
Buy
18.06%
Upside
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elanco Animal Health

3 Months
Steve ScalaTD Cowen
Success Rate
10/15 ratings generated profit
67%
Average Return
+12.59%
Copying Steve Scala's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +12.59% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
20/29 ratings generated profit
69%
Average Return
+28.32%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 68.97% of your transactions generating a profit, with an average return of +28.32% per trade.
2 Years
Jonathan BlockStifel Nicolaus
Success Rate
19/25 ratings generated profit
76%
Average Return
+42.40%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 76.00% of your transactions generating a profit, with an average return of +42.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ELAN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
1
Buy
16
13
16
12
15
Hold
1
1
2
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
14
18
16
20
In the current month, ELAN has received 16 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. ELAN average Analyst price target in the past 3 months is 31.33.
Each month's total comprises the sum of three months' worth of ratings.

ELAN Financial Forecast

ELAN Earnings Forecast

Next quarter’s earnings estimate for ELAN is $0.20 with a range of $0.18 to $0.24. The previous quarter’s EPS was $0.34. ELAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ELAN is $0.20 with a range of $0.18 to $0.24. The previous quarter’s EPS was $0.34. ELAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.

ELAN Sales Forecast

Next quarter’s sales forecast for ELAN is $1.21B with a range of $1.20B to $1.22B. The previous quarter’s sales results were $1.37B. ELAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.
Next quarter’s sales forecast for ELAN is $1.21B with a range of $1.20B to $1.22B. The previous quarter’s sales results were $1.37B. ELAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.

ELAN Stock Forecast FAQ

What is ELAN’s average 12-month price target, according to analysts?
Based on analyst ratings, Elanco Animal Health’s 12-month average price target is 31.33.
    What is ELAN’s upside potential, based on the analysts’ average price target?
    Elanco Animal Health has 23.31% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ELAN a Buy, Sell or Hold?
          Elanco Animal Health has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Elanco Animal Health’s price target?
            The average price target for Elanco Animal Health is 31.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $34.00 ,the lowest forecast is $26.00. The average price target represents 23.31% Increase from the current price of $25.41.
              What do analysts say about Elanco Animal Health?
              Elanco Animal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of ELAN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.